Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT.
Status:
Recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety for the prevention of oral mucositis and PK of MIT-001 for
lymphoma or multiple myeloma patients receiving conditioning chemotherapy for autologous
hematopoietic stem cell transplantation(auto-HSCT).